Canada to speed access to OTCs

Article Date: 02/05/2012 07:50
Canada to speed access to OTCs

Vacancy Search

Quick job search

Advanced Search

Latest News

US will review Actelion's new PAH drug

US will review Actelion's new PAH drug

EU OKs Pfizer's pneumonia jab for adults

EU OKs Pfizer's pneumonia jab for adults

AZ, Cambridge Uni link to support biotech start-ups

AZ, Cambridge Uni link to support biotech start-ups

BI files Pradaxa antidote in US, EU and Canada

BI files Pradaxa antidote in US, EU and Canada

GSK sells Australian opiates business to Sun Pharma

GSK sells Australian opiates business to Sun Pharma

NICE backs Gilead's Harvoni for Hep C

NICE backs Gilead's Harvoni for Hep C

Cardinal-Cordis deal highlights genericisation of medtech

Two $1bn-plus deals in a single day, and three in a week – looks like medtech M&A madness is back on. The announcement of the Boston-AMS deal yesterday preceded news of Cardinal Health’s...

Novartis sees past Lucentis’s decline

Having been outmanoeuvred first on price and then on dosing, Novartis is preparing its next line of defence in macular degeneration as sales of its flagship Lucentis plateau.

Amgen still in play with Endeavor to expand Kyprolis

Amgen had already made strides to boost Kyprolis’s relevance in the multiple myeloma market, and the most important aspect of yesterday’s interim analysis of the Endeavor study is that it...

J&J sells Cordis to Cardinal for $1.94bn

J&J sells Cordis to Cardinal for $1.94bn
more news